Pharmarise Holdings Corporation (2796.T)
JPY 563.0
(-2.26%)
JPY 563.0
(-2.26%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 54.46 Billion | 52.03 Billion | 51.6 Billion | 52.32 Billion | 51.03 Billion | 51.72 Billion |
| Cost of Revenue | 46.57 Billion | 43.89 Billion | 43.49 Billion | 44.25 Billion | 43.59 Billion | 44.38 Billion |
| Gross Profit | 7.89 Billion | 8.13 Billion | 8.11 Billion | 8.06 Billion | 7.43 Billion | 7.34 Billion |
| Operating Expenses | 7.53 Billion | 6.69 Billion | 6.59 Billion | 6.82 Billion | 6.4 Billion | 6.7 Billion |
| Selling, General and Administrative Expenses | 4.37 Billion | 3.72 Billion | 3.52 Billion | 3.66 Billion | 3.47 Billion | 3.66 Billion |
| Research and Development Expenses | 12 Million | 13 Million | 10 Million | 21 Million | 9 Million | 13 Million |
| Other Expenses | 3.15 Billion | 32 Million | -7 Million | 21 Million | 24 Million | -15 Million |
| Cost and Expenses | 53.55 Billion | 50.59 Billion | 50.08 Billion | 51.07 Billion | 49.99 Billion | 51.08 Billion |
| Operating Income | 916 Million | 1.43 Billion | 1.52 Billion | 1.24 Billion | 1.03 Billion | 640 Million |
| Interest Expense | 66 Million | 55 Million | 65 Million | 75 Million | 74 Million | 82 Million |
| Income Tax Expense | 485 Million | 702 Million | 863 Million | 782 Million | 238 Million | 409 Million |
| Earnings before Tax | 143 Million | 1.04 Billion | 1.32 Billion | 1.2 Billion | 819 Million | 400 Million |
| Net Income | -351 Million | 333 Million | 447 Million | 426 Million | 577 Million | 23 Million |
| Earnings Per Share Basic | -33.35 | 35.42 | 47.90 | 45.78 | 61.03 | 2.51 |
| Earnings Per Share Diluted | -33.35 | 26.86 | 36.22 | 34.59 | 46.32 | 2.12 |
| Weighted Average Shares Outstanding | 10.52 Million | 9.4 Million | 9.33 Million | 9.3 Million | 9.45 Million | 9.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.52 Million | 12.47 Million | 12.39 Million | 12.37 Million | 12.5 Million | 10.84 Million |
| Gross Margin | 0.14 | 0.16 | 0.16 | 0.15 | 0.15 | 0.14 |
| EBIT Margin | 0.04 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 |
| Profit Margin | -0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| EBITDA | 2.08 Billion | 2.66 Billion | 2.82 Billion | 2.59 Billion | 2.26 Billion | 1.86 Billion |
| Earnings Before Tax Margin | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 15.23 Billion | 13.79 Billion | 54.46 Billion | 13.72 Billion | 13.47 Billion | 13.47 Billion |
| Cost of Revenue | 13.09 Billion | 11.93 Billion | 46.57 Billion | 11.68 Billion | 11.33 Billion | 11.34 Billion |
| Gross Profit | 2.13 Billion | 1.85 Billion | 7.89 Billion | 2.04 Billion | 2.14 Billion | 2.13 Billion |
| Operating Expenses | 2.08 Billion | 1.8 Billion | 6.97 Billion | 1.89 Billion | 1.76 Billion | 1.79 Billion |
| Selling, General and Administrative Expenses | 2.08 Billion | 1.79 Billion | - | 1.88 Billion | 1.61 Billion | 1.79 Billion |
| Research and Development Expenses | - | 3 Million | - | 3 Million | 3 Million | 3 Million |
| Other Expenses | 1 Million | 3 Million | -2.6 Billion | -40 Million | 1 Million | 17 Million |
| Cost and Expenses | 15.17 Billion | 13.73 Billion | 53.55 Billion | 13.57 Billion | 13.09 Billion | 13.14 Billion |
| Operating Income | 52 Million | 53 Million | 916 Million | 152 Million | 379 Million | 331 Million |
| Interest Expense | 30 Million | 24 Million | 66 Million | 14 Million | 15 Million | 13 Million |
| Income Tax Expense | 156 Million | -88 Million | 485 Million | 194 Million | 194 Million | 185 Million |
| Earnings before Tax | 23 Million | -618 Million | 143 Million | 99 Million | 350 Million | 312 Million |
| Net Income | -131 Million | -528 Million | -351 Million | -97 Million | 150 Million | 123 Million |
| Earnings Per Share Basic | -11.65 | -46.96 | - | -8.51 | 15.12 | 13.05 |
| Earnings Per Share Diluted | -11.65 | -46.96 | - | -8.51 | 15.12 | 9.84 |
| Weighted Average Shares Outstanding | 11.24 Million | 11.24 Million | 10.52 Million | 11.4 Million | 9.92 Million | 9.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.24 Million | 11.24 Million | 10.52 Million | 11.4 Million | 9.92 Million | 12.49 Million |
| Gross Margin | 0.14 | 0.13 | 0.14 | 0.15 | 0.16 | 0.16 |
| EBIT Margin | 0.02 | 0.03 | - | 0.03 | 0.03 | 0.03 |
| Profit Margin | -0.01 | -0.04 | -0.01 | -0.01 | 0.01 | 0.01 |
| EBITDA | 345.5 Million | 355 Million | - | 449 Million | 386 Million | 344 Million |
| Earnings Before Tax Margin | 0.00 | 0.00 | 0.02 | 0.01 | 0.03 | 0.02 |
ATRX
ARKO
0703
FHTX
8923
EXPO